NCT04401579: A reported trial by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04401579 |
|---|---|
| Title | A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (ACTT-2) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | May 8, 2020 |
| Completion date | July 31, 2020 |
| Required reporting date | July 31, 2021, midnight |
| Actual reporting date | Feb. 25, 2021 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |